Stroke treatment enters the Fas lane

Cell Death Differ. 2001 Jul;8(7):659-61. doi: 10.1038/sj.cdd.4400899.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adult
  • Animals
  • Apoptosis
  • Brain / metabolism*
  • Brain / pathology
  • Brain Ischemia / metabolism
  • Brain Ischemia / pathology
  • Fas Ligand Protein
  • Humans
  • Infarction, Middle Cerebral Artery / drug therapy
  • Infarction, Middle Cerebral Artery / genetics
  • Infarction, Middle Cerebral Artery / metabolism
  • Membrane Glycoproteins / antagonists & inhibitors
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / metabolism*
  • Mice
  • Mice, Knockout
  • Stroke / drug therapy*
  • Stroke / genetics
  • Stroke / metabolism*
  • Stroke / pathology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • FASLG protein, human
  • Fas Ligand Protein
  • Fasl protein, mouse
  • Membrane Glycoproteins
  • Tumor Necrosis Factor-alpha